Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma

被引：11
作者：
Crisafulli, Ernesto [1 ]
Zanini, Andrea [2 ]
Pisi, Giovanna [3 ]
Pignatti, Patrizia [4 ]
Poli, Gianluigi [5 ]
Scuri, Mario [5 ]
Chetta, Alfredo [1 ]
机构：
[1] Univ Parma, Dept Clin & Expt Med, Resp Dis & Lung Funct Unit, Via Gramsci 14, I-43126 Parma, Italy
[2] Malcantonese Hosp, Giuseppe Rossi Fdn, Div Internal & Resp Med, Castelrotto, Switzerland
[3] Univ Hosp, Dept Paediat, Cyst Fibrosis Unit, Parma, Italy
[4] Salvatore Maugeri Fdn IRCCS, Allergy & Immunol Unit, Pavia, Italy
[5] Chiesi Farmaceut SpA, Parma, Italy
来源：
EXPERT REVIEW OF RESPIRATORY MEDICINE | 2016年 / 10卷 / 05期
关键词：
Asthma; small airways; inflammation; beclometasone dipropionate; formoterol fumarate; extrafine; fixed combination; pMDI; DPI; LONG-ACTING BETA(2)-AGONISTS; AIRWAY SMOOTH-MUSCLE; SINGLE INHALER; REAL-LIFE; BECLOMETHASONE DIPROPIONATE/FORMOTEROL; FLUTICASONE PROPIONATE; SCIENTIFIC RATIONALE; PATIENT PERSPECTIVES; ADULT PATIENTS; LUNG-FUNCTION;
D O I：
10.1586/17476348.2016.1161508
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Inhaled therapy is often considered the cornerstone of asthma management and international guidelines recommend combination therapy of inhaled corticosteroids (ICS) and long-acting-beta2-agonists (LABA) in a large proportion of asthmatic patients. The effectiveness of ICS/LABA is dependent on the correct choice of device and proper inhalation technique, this influences drug delivery and distribution along the bronchial tree, including the most peripheral airways. The fixed combination of beclometasone dipropionate/formoterol fumarate (BDP/FF) is the only extrafine formulation available in pressurized metered dose inhaler (pMDI) and in dry powder inhaler (DPI). Here, we focus on the recent significant advances regarding BDP/FF fixed combination for the treatment of asthma.
引用
收藏
页码：481 / 490
页数：10
相关论文
共 60 条
  • [1] Advances in asthma and COPD management:: Delivering CFC-free inhaled therapy using Modulite® technology
    Acerbi, D.
    Brambilla, G.
    Kottakis, I.
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2007, 20 (03) : 290 - 303
  • [2] Glucocorticoid receptor localization in normal and asthmatic lung
    Adcock, IM
    Gilbey, T
    Gelder, CM
    Chung, KF
    Barnes, PJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) : 771 - 782
  • [3] Small airway dysfunction is associated to excessive bronchoconstriction in asthmatic patients
    Alfieri, Veronica
    Aiello, Marina
    Pisi, Roberta
    Tzani, Panagiota
    Mariani, Elisa
    Marangio, Emilio
    Olivieri, Dario
    Nicolini, Gabriele
    Chetta, Alfredo
    [J]. RESPIRATORY RESEARCH, 2014, 15
  • [4] Real-life prospective study on asthma control in Italy: Cross-sectional phase results
    Allegra, Luigi
    Cremonesi, Giovanni
    Girbino, Giuseppe
    Ingrassia, Eleonora
    Marsico, Serafino
    Nicolini, Gabriele
    Terzano, Claudio
    [J]. RESPIRATORY MEDICINE, 2012, 106 (02) : 205 - 214
  • [5] [Anonymous], 2015, GLOB STRAT ASTHM MAN
  • [6] Scientific rationale for using a single inhaler for asthma control
    Barnes, P. J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (03) : 587 - 595
  • [7] Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids
    Barnes, PJ
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (01) : 182 - 191
  • [8] How do corticosteroids work in asthma?
    Barnes, PJ
    Adcock, IM
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (05) : 359 - 370
  • [9] Bateman Eric D, 2003, Am J Respir Med, V2, P275
  • [10] The role of small airway disease in asthma
    Bjermer, Leif
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (01) : 23 - 30
123456